To explore the role of MyD88 in NAFLD-related liver cancer, SMAMyD88−/− and MyD88fl/fl mice were first treated with an intraperitoneal injection of 50 μg/g DEN (Sigma-Aldrich, St. This evidence concerns the gene MYD88 and liver cancer.